Radium‐223 dichloride treatment in metastatic castration‐resistant prostate cancer in Finland: A real‐world evidence multicenter study-Reference-Cited by-同舟云学术

Radium‐223 dichloride treatment in metastatic castration‐resistant prostate cancer in Finland: A real‐world evidence multicenter study

Published:2022-09-26 Issue:4 Volume:12 Page:4064-4076
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Hyväkkä Anniina¹^ORCID,Kääriäinen Okko‐Sakari²,Utriainen Tapio³,Löyttyniemi Eliisa⁴,Mattila Kalle⁵,Reinikainen Petri⁶,Sormunen Jorma⁶⁷,Jääskeläinen Minna⁸⁹,Auvinen Päivi²,Minn Heikki⁵^ORCID,Sundvall Maria¹^ORCID

Affiliation:

1. Cancer Research Unit, Institute of Biomedicine, and Department of Oncology FICAN West Cancer Center, University of Turku, Turku University Hospital Turku Finland

2. Department of Oncology Kuopio University Hospital Kuopio Finland

3. Helsinki University Hospital Comprehensive Cancer Center Helsinki Finland

4. Department of Biostatistics, Institute of Clinical Medicine University of Turku Turku Finland

5. Department of Oncology and FICAN West Cancer Center University of Turku, Turku University Hospital Turku Finland

6. Department of Oncology Tampere University Hospital Tampere Finland

7. Docrates Cancer Center Helsinki Finland

8. Department of Oncology Oulu University Hospital Oulu Finland

9. Department of Oncology Lapland Central Hospital Rovaniemi Finland

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology